Investor Relations

Our community's dedication to patient care and our focus on creating value for our partners has allowed us to grow each year since 2008, our first full year since we relaunched as a stand-alone company. We are well positioned to continue our growth, based on our diversified growth strategy - partnering with health plans, medical groups and health systems - through organic growth, de novo (new build) projects and acquisitions

*2015 impacted by higher interest expense due to the debt refinancing in March 2015. Excluding the impact of increased interest expense due to the debt refinancing, adjusted net income per diluted share in 2015 would have been $2.23.

*Net debt leverage ratio defined as total debt, less cash and cash equivalents, divided by EBITDA less NCI for the twelve months then ended


The Company does not undertake any responsibility for updating information that is posted. All data posted on the Investor Relations section of this website will show the date the material was issued.

The graphs above include "unaudited non-GAAP financial measures" as defined in Regulation G under the Securities Exchange Act of 1934, as amended, including Adjusted EBITDA-NCI and Adjusted Net Income per Diluted Share. We believe that the presentation of non-GAAP financial measures helps investors analyze underlying trends in our business, evaluate the performance of our business both on an absolute basis and relative to our peers and the broader market, provides useful information to both management and investors by excluding certain items that may not be indicative of the core operating results and operational strength of our business and helps investors evaluate our ability to service our debt. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similar measures presented by other companies. The presentation of non-GAAP financial measures is not intended to be a substitute for, and should not be considered in isolation from, the financial measures reported in accordance with GAAP. Systemwidegrowth measures should not be considered substitutes for and are not comparable to GAAP financial measures. Systemwidegrowth measures are intended as supplemental measures of our performance. See the tables below for a reconciliation of the non-GAAP financial measures disclosed above to their comparable GAAP financial measures.

Reconciliation Tables

Shareholder Tools